atezolizumab,bevacizumab
roche
['imbrave050', 'atezo', 'hcc']
great abstract from #asco23 ! learn more about the efficacy, safety &amp; pt reported outcome from the phase iii imbrave050 trial of adjuvant (atezo) + (bev) vs active surveillance in pts with #hcc at high risk of disease recurrence following resection
#meded 
COR2ED bringing you Independent Medical Education developed 
by HCC CONNECT, international experts in Liver oncology